How To Share Glp1 Progress With Your Doctor

Knowing how to share GLP-1 progress with your doctor makes every appointment more productive. This share GLP-1 progress with doctor resource covers the important information you need to make informed decisions. Your provider has limited time, and the better you prepare, the better decisions they can make about your treatment. If you're seeing a FormBlends provider or your primary care physician, organized progress data leads to more personalized care. In this guide, we cover what information to bring, how to present it, and how to get the most out of every visit.

Key Takeaways: - Understand what your doctor needs to see - Learn how to organize your progress report - Making the Most of Limited Appointment Time - Understand what to discuss during key treatment phases - Talking to Multiple Providers About Your GLP-1 Treatment

What Your Doctor Needs to See

Providers make clinical decisions based on data. The more relevant data you bring, the more informed those decisions become. Here is what your doctor needs to evaluate your GLP-1 treatment.

Weight trend data. Not just today's weight, but your weight over the past 4-8 weeks. A trend line showing consistent loss, a plateau, or a rebound gives your provider context that a single number can't. Include your starting weight, current weight, and the dates of each reading.

Current dose and titration history. Your provider needs to know your current medication dose and when each dose change occurred. If you switched from one GLP-1 medication to another, include that history as well. This helps them correlate your results and side effects with specific dose levels.

Side effect log. A summary of side effects, including type, severity, and duration. Specifically, note which side effects improved over time, which persisted, and any new ones that appeared after dose changes. Your provider uses this to decide whether to continue titrating, hold at the current dose, or try a different approach.

Nutrition summary. You don't need to bring a food diary for every meal, but general information about your protein intake, meal frequency, and any dietary challenges is valuable. If you have been struggling to eat enough protein or dealing with food aversions, your provider needs to know.

Exercise activity. A brief overview of what type of exercise you're doing and how often. Your provider can use this to assess whether you're doing enough resistance training to preserve muscle mass.

Lab results. If you have had recent blood work, bring the results. Key markers include fasting glucose, HbA1c, lipid panel, and liver function tests. These help your provider assess the metabolic benefits of your treatment beyond weight loss.

For a deeper understanding of what to expect during treatment, read .

How to Organize Your Progress Report

"The key to successful GLP-1 therapy is setting realistic expectations and supporting patients through the titration phase. The side effects are manageable for most people, but they need to know what to expect.") Dr. Caroline Apovian, MD, Harvard Medical School

View data table

Bar chart showing lifestyle factors impact on glp-1 results: Protein Intake (90), Exercise (85), Sleep Quality (78), Hydration (72), Stress Mgmt (65)

Category	Impact on Treatment Outcomes (%)	Detail
Protein Intake	90	Preserves muscle mass
Exercise	85	Enhances weight loss
Sleep Quality	78	Supports metabolism
Hydration	72	Reduces side effects
Stress Mgmt	65	Cortisol reduction

Bringing a one-page summary to your appointment is the most effective approach. Here is a simple format that works well.

Section 1: Quick Stats Start date, current weight, total weight lost, current dose, weeks on treatment. This gives your provider an instant snapshot.

Section 2: Weight Trend A simple chart or list showing your weekly weights for the past 4-8 weeks. The can generate this chart automatically and display it as a clean trend line.

Section 3: Side Effects Summary List each side effect, its severity (mild/moderate/severe), when it started, and whether it improved. Highlight anything that's currently bothering you.

Section 4: Lifestyle Notes Brief notes on your protein intake (approximate grams per day), exercise frequency and type, sleep quality, and energy levels.

Section 5: Questions Write down 2-3 questions you want to ask. Common questions include: Should my dose increase? When should I schedule my next lab work? Is my rate of weight loss appropriate? How can I manage constipation better?

Having this organized in advance prevents the common situation where you leave the appointment and immediately remember the question you forgot to ask.

---

Free Download: GLP-1 Progress Report Template A printable one-page template with sections for stats, trends, side effects, lifestyle notes, and questions. Fill it in before each appointment. Get yours free (we'll email it to you instantly. [Download Now]

---

Making the Most of Limited Appointment Time

Provider appointments are often short. Here is how to maximize the value of every minute.

Lead with the most important issue. If you're having a specific problem, like persistent nausea that isn't improving, bring it up first. Don't save your most pressing concern for the end when time is running out.

Be specific, not vague. Instead of "I'm not doing well," say "My nausea has been 6/10 for the past two weeks despite trying smaller meals, and it's affecting my ability to eat enough protein." Specificity gets you specific solutions.

Hand over your progress report. Give your one-page summary to your provider at the start of the appointment. This lets them scan the data quickly while you explain the highlights verbally. Some providers prefer digital reports, so ask their preference.

Take notes during the appointment. Write down your provider's recommendations so you can follow them accurately. If they change your dose or suggest a new strategy, having it in writing prevents confusion later.

Confirm next steps before you leave. Repeat back what you understood. "So I'm staying at this dose for two more weeks, then increasing. I should focus on getting more protein and come back in four weeks?" This ensures you and your provider are on the same page.

Schedule your next appointment before leaving. This keeps you accountable and ensures you get a time slot that works for your schedule. Regular follow-ups are important during active titration.

For tips on tracking the metrics your provider cares about, read .

What to Discuss During Key Treatment Phases

Different phases of your GLP-1 treatment call for different conversations with your provider.

Initial titration (months 1-4): Focus on side effect management, eating enough food (especially protein), and adjusting to the medication. Key questions: Is the side effect I'm experiencing normal? Am I titrating at the right pace? Should I slow down my dose increases?

Active weight loss (months 4-12): Focus on rate of loss, body composition, and any emerging concerns. Key questions: Is my rate of weight loss healthy? Am I preserving muscle mass? Should I add any supplements or adjust my exercise?

Plateau management (variable timing): Focus on what the data shows versus what the scale shows. Key questions: Is this a true plateau or normal fluctuation? Should we adjust the dose? Are there dietary changes that might help?

Maintenance phase: Focus on long-term strategy, dose adjustments for weight maintenance, and preventing regain. Key questions: What is my maintenance dose? How do I know if I need to increase again? What are the signs of early weight regain?

Medication changes or discontinuation: Focus on transition planning. Key questions: How do I taper safely? What lifestyle changes should I have in place first? How will I monitor for weight regain?

The can help you prepare for each of these conversations by generating phase-specific reports.

Talking to Multiple Providers About Your GLP-1 Treatment

Many GLP-1 patients work with more than one healthcare provider. You might see a FormBlends provider for your medication and a primary care physician for general health. Coordinating between providers is important.

Keep all providers informed. Let your PCP know about your GLP-1 treatment, including the specific medication, dose, and how long you have been on it. Similarly, tell your FormBlends provider about any medications or supplements your PCP prescribes.

Share lab results across providers. If your PCP orders blood work, share the results with your FormBlends provider and vice versa. This prevents duplicate testing and ensures everyone has the same information.

Clarify who manages what. If both providers can prescribe GLP-1 medications, clarify who is managing your GLP-1 protocol to avoid confusion. Having one provider as the primary manager of your weight loss medication prevents conflicting recommendations.

Bring a medication list. Maintain a current list of all medications, including your GLP-1 medication, other prescriptions, over-the-counter drugs, and supplements. Share this list with every provider you see.

For more on getting started with a FormBlends provider, check .

Frequently Asked Questions

What if my doctor isn't familiar with compounded GLP-1 medications?

Some primary care physicians may not be experienced with compounded semaglutide or tirzepatide. Bring information about your specific medication, including the pharmacy that prepared it and the prescribing provider's contact information. You can also ask your FormBlends provider to communicate directly with your PCP if questions arise.

How often should I see my provider during GLP-1 treatment?

During active titration, most providers recommend visits every 4-6 weeks. Once you reach your maintenance dose and progress is stable, visits can decrease to every 8-12 weeks. Your provider will set a schedule based on your individual needs.

Should I bring my tracking app data or a printed report?

Ask your provider which format they prefer. Some providers like to scroll through app data on a phone screen. Others prefer a printed summary they can scan quickly and add to your chart. Either format works as long as the key data points are included.

What if I disagree with my provider's recommendation?

Express your concerns clearly and ask for the reasoning behind their recommendation. A good provider will explain their thinking and consider your perspective. If you have data that supports a different approach, share it. the decision about your health is yours, and you should feel comfortable with your treatment plan.

How do I request specific lab tests during my treatment?

Ask your provider which labs are indicated at your current treatment stage. Common requests include a metabolic panel, lipid panel, HbA1c, and thyroid function. If you have concerns about a specific health marker, ask your provider whether testing is appropriate. Most providers welcome proactive patients.

Start your experience Today

Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you) consultations are free and confidential.

---

Medical References

1. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
2. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
3. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
4. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
5. Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
6. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2^[1] (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3^[2] (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5^[3] (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2^[4] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
8. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3^[5] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
9. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4^[6] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
10. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
11. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
12. Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24